Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on June 7, 2016, to disclose information that will be shared with securities analysts and investors during meetings scheduled between June 7 and June 30, 2016. The primary purpose of this disclosure is to reaffirm the company's full-year 2016 net income guidance. Specifically, the company expects net income to be greater than $9.65 per share, which includes over $1.15 per share of net unfavorable items. Excluding these items, the adjusted net income guidance remains strong, with the company continuing to expect it to be greater than $10.80 per share. This guidance is based on information available as of the first quarter of 2016 and does not incorporate any further adjustment items.
Key Highlights
- 1Reaffirmation of 2016 full-year net income guidance.
- 2Projected net income to be greater than $9.65 per share.
- 3Anticipated net unfavorable items to be greater than $1.15 per share.
- 4Continued expectation for adjusted net income to be greater than $10.80 per share.
- 5Guidance does not include adjustment items beyond those reported in Q1 2016 earnings release.
- 6Information intended for discussions with securities analysts and investors.
- 7Forward-looking statements included, highlighting associated risks and uncertainties.